Navigation Links
Over-the-counter eardrops may cause hearing loss or damage
Date:1/28/2008

The Montreal Children's Hospital of the MUHC recommends these products be

used with extreme caution

MONTREAL, Jan. 28 /PRNewswire/ - A new study, led by researchers at The Montreal Children's Hospital (MCH) of the MUHC, has revealed that certain over-the-counter earwax softeners can cause severe inflammation and damage to the eardrum and inner ear. The results of the study, recently published in The Laryngoscope, suggest that use of these medications should be discouraged.

"Patients often complain that wax is blocking their ears and is causing discomfort and sometimes deafness," says Dr. Sam Daniel principal investigator of the study and director of McGill Auditory Sciences Laboratory at The Children's. "Over-the-counter earwax softeners are used to breakup and disperse this excess wax. However, the effects of these medications on the cells of the ear had not been thoroughly analyzed."

"Because some of these products are readily available to the public without a consultation with or prescription from a physician, it is important to make sure they are safe to use. Our study shows that in a well-established animal model, one such product, Cerumenex, is in fact, toxic to the cells of the ear," says Dr. Daniel.

Dr. Daniel and his team studied the impact of Cerumenex on hearing. In addition, overall toxicity in the outer ear and changes in the nerve cells of the inner ear were analyzed.

"Harmful effects to many of the cells were observed after only one dose," says Dr. Melvin Schloss co-author and MCH Director of Otolaryngology. "We observed reduced hearing, severe inflammation, and lesions to the nerve cells."

"We believe these findings are applicable to humans," add Dr. Daniel. "The animal model we chose has been widely used to test toxicity. In addition, this model has a very similar hearing mechanism. Overall, our findings suggest that Cerumenex has a toxic potential and it should be used with ca
'/>"/>

SOURCE THE MONTREAL CHILDREN'S HOSPITAL
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement from the Consumer Healthcare Products Association on the Safety of Pediatric Over-the-Counter Medicines
2. Statement from the Consumer Healthcare Products Association on Todays Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines
3. Horphags Prelox provides over-the-counter solution
4. Horphags Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction
5. Consumers Union Opposes Over-the-Counter Cholesterol Drug
6. FDA Panel to Consider Over-the-Counter Statin
7. FDA Panel Considering Over-the-Counter Statin
8. FDA Advisers Reject Over-the-Counter Statin
9. CHPA Lends Support to FDAs Announcement Against Use of Oral, Over-the-Counter Cough and Cold Medicines in Children Under Two
10. Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec
11. Over-the-counter eardrops may cause hearing loss or damage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...r and sanitation severely limited in Lebanon due t...ncies have stepped up preparations for a coordinat...ess to health care for injured and patients with c...h attacks on July 12. WHO said it is assistin...
...t after memory begins to decline, executive functi...e progression from mild cognitive// impairment, a ...disease. Ron Petersen, M.D., Ph.D., Mayo Cli... "If someone with mild cognitive impairment start...
...ases the risk of hospitalization and death from he... absence of established// risk factors, says a stu... Association. An assistant professor of pre... in early life with hospitalization and subsequent...
... going by the current trends tobacco will probably...e almost 10 times the toll// it took in the 20th c...r of the American Cancer Society said, "In all of ...ncer, 1 in 5 death due to cancer is due to tobacco...
...hout Africa could help to avert about 5,7-million ... that was published in Public Library of Science M... 300 000 deaths and about two million new infectio... circumcision reduces male vulnerability to HIV in...
...ve birth to triplets through IVF procedure three y...ut any infertility treatments. She gave birth to t... because they're healthy and so am I," Magdaleno s...'m happy but, I don't know. I don't know how to ex...
Other Medicine News:Health News:Decline in Concentration, Decision-Making and Problem-Solving 2Health News:Tobacco Epidemic On The Rise 2Health News:Circumcision to Avert HIV Infection 2
(Date:11/27/2009)...Minn, Nov. 27 ACUO TECHNOLOGIES, d...ment software, data migration tools and services, ...nt and Trademark Office has approved a patent appl...a Computer Network." Acuo Technologies is pleased ...ctual property. In general, the granted patent app...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)...Fla., Nov. 25 American...he Company") is pleased to announce that they have...ment office in Shanghai, China. ,, ASR has been...sential gateway for the development and production...for children and adults to be distributed and sold...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3
...entative medicine doctors say they are outraged,ov...rescribing,human growth hormone to treat a hormone...BEACH, Fla., April 27, 2007 /PRNewswire/ -- The ad...enter of a recent New,York Times article about the...dicine (<a target="_blank" href=,"http://worldheal...
...: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",a...ab-stops: list .5in; mso-list: l1 level1 lfo2">, <...othic MT,; mso-bidi-font-weight: bold">,Independen... adding,Diovan to conventional therapy , , , ,<...in; mso-list: l1 level1 lfo2">, <span style=,"FONT...
Other Medicine Technology:Doctors Outraged Over Growth Hormone Controversy 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
Blue Line® Intubation Stylet 7.5 mm 10 mm
Lighted Pediatric Stylet - Non-Sterile
Surch-Lite™ Flexible Light - 15" Non-Sterile
Peripheral Nerve Stimulator Electrodes
Medicine Products: